Impact of Huntington's across the entire disease spectrum: the phases and stages of disease from the patient perspective

A K Ho, M B Hocaoglu, European Huntington's Disease Network Quality of Life Working Group, A K Ho, M B Hocaoglu, European Huntington's Disease Network Quality of Life Working Group

Abstract

Although Huntington's disease (HD) is a neurodegenerative disease characterized by motor, cognitive and behavioural disturbances, there has been little empirical data examining what patients are most concerned about throughout the different stages of disease, which can span many years. Semi-structured face-to-face interviews were individually conducted with 31 people living with different stages of Huntington's, from pre-clinical gene carriers to advanced stage. We examined how often participants raised issues and concerns regarding the impact of Huntington's on everyday life. The Physical/functional theme hardly featured pre-clinically, but was strongly present from Stage 1, rose steadily and peaked at Stage 5. There were no significant changes between stages for the Emotional, Social, and Self themes that all featured across all stages, indicating that these issues were not raised more frequently over the course of the disease. Likewise, the more rarely mentioned Financial and Legal themes also remained similar across stages. However, the Cognitive theme only featured between Stages 1 and 4, and hardly at all pre-clinically and at Stage 5. These findings provide insight into patients' important and unique perspective and have implications for the management and development of interventions across the spectrum of HD stages.

2011 John Wiley & Sons A/S.

Figures

Figure 1
Figure 1
Average frequency (%) for each theme according to Huntington's disease stage.

References

    1. Helder DI, Kaptein AA, van Kempen GMJ, van Houwelingen JC, Roos RAC. Impact of Huntington's disease on quality of life. Mov Disord. 2001;16(2):325–330.
    1. Ho AK, Gilbert AS, Mason SL, Goodman AO, Barker RA. Health-related quality of life in Huntington's disease: which factors matter most? Mov Disord. 2008;24(4):572–576.
    1. Dawson SF, Kristjanson LJ, Toye CM, Flett P. Living with Huntington's disease: need for supportive care. Nursing & Health Sciences. 2004;6(2):123–130.
    1. Richards F. Couples' experiences of predictive testing and living with the risk or reality of Huntington disease: a qualitative study. Am J Med Genet A. 2004;126A(2):170–182.
    1. Shoulson IF, Fahn S. Huntington disease: clinical care and evaluation. Neurology. 1979;29(1):1–3.
    1. Fitzpatrick R. Alternative approaches to assessment of health-related quality of life. In: Offer A, editor. In pursuit of the quality of life. Oxford: Oxford University Press; 1996. p. 161.
    1. Ferm U, Sahlin A, Sundin L, Hartelius L. Using talking mats to support communication in persons with Huntington's disease. Int J Lang Commun Disord. 2010;45(5):523–536.
    1. Ho AK, Robbins AO, Barker RA. Huntington's disease patients have selective problems with insight. Mov Disord. 2006;21(3):385–389.
    1. Karlsen KH, Tandberg E, Årsland D, Larsen JP. Health related quality of life in Parkinson's disease: a prospective longitudinal study. J Neurol Neurosurg Psychiatry. 2000;69(5):584–589.
    1. Albert SM, Jacobs DM, Sano M, et al. Longitudinal study of quality of life in people with advanced Alzheimer's disease. Am J Geriatr Psychiatry. 2001;9(2):160–168.
    1. Schrag A, Jahanshahi M, Quinn N. How does Parkinson's disease affect quality of life? A comparison with quality of life in the general population. Mov Disord. 2000;15(6):1112–1118.

Source: PubMed

3
Subscribe